this post was submitted on 10 Aug 2024
91 points (98.9% liked)

3DPrinting

15597 readers
169 users here now

3DPrinting is a place where makers of all skill levels and walks of life can learn about and discuss 3D printing and development of 3D printed parts and devices.

The r/functionalprint community is now located at: !functionalprint@kbin.social or !functionalprint@fedia.io

There are CAD communities available at: !cad@lemmy.world or !freecad@lemmy.ml

Rules

If you need an easy way to host pictures, https://catbox.moe/ may be an option. Be ethical about what you post and donate if you are able or use this a lot. It is just an individual hosting content, not a company. The image embedding syntax for Lemmy is ![](URL)

Moderation policy: Light, mostly invisible

founded 1 year ago
MODERATORS
 

Stratasys is losing ground because their massively overpriced ecosystem is getting outclassed by literally everything else in the market. So why improve if you can just sue your competition out of the US market?

you are viewing a single comment's thread
view the rest of the comments
[–] riskable@programming.dev 13 points 3 months ago* (last edited 3 months ago)

It's not just actually innovative patents that are missing from the patent system (which they are). It has also become so expensive to both file and litigate a patent that only big businesses and patent trolls can afford it.

The median cost to litigate a patent is five fucking million dollars (in 2021). What this means is that if your patented solution isn't worth at least 2x that amount it is quite simply not worth patenting.

The whole system should be scrapped. It was fundamentally flawed from the start and has demonstrated over and over again that it does not scale. It's not even worth it to keep pharmaceutical patents (there's other, better, cheaper ways to come up with new drugs than $100 billion dollar commercial entities ripping us all off and spending half their budgets on marketing).